|
Market Closed -
Hong Kong S.E.
01:38:55 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 25.80 HKD | -3.87% |
|
-11.70% | -26.12% |
| 27/08 | CanSino Biologics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 26/08 | CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines | MT |
| Market Cap | 1.02TCr 1.19TCr 151.56Cr 130.58Cr 123.65Cr 112.07Cr 210.26Cr 14TCr 211.32Cr 1.47TCr 564.71Cr 7.37TCr 569.2Cr 556.71Cr 23TCr | P/E 2026 * |
50.6x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 1.02TCr 1.19TCr 151.92Cr 130.89Cr 123.94Cr 112.34Cr 210.75Cr 15TCr 211.82Cr 1.47TCr 566.05Cr 7.38TCr 570.54Cr 558.03Cr 23TCr | EV / Sales 2026 * |
7.08x | EV / Sales 2027 * | 5.84x |
| Free-Float |
39.3% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 6185 | Delayed | |
OTC Markets
| CASBF | Delayed | |
|
Börse Stuttgart
| CJH | Delayed | |
|
Deutsche Boerse AG
| CJH | Delayed | |
|
Tradegate
| CJH | Real-time | |
|
Boerse Muenchen
| CJH | Real-time |
| 1 day | -3.87% | ||
| 1 week | -11.70% | ||
| Current month | -12.54% | ||
| 1 month | +4.62% | ||
| 3 months | +11.30% | ||
| 6 months | -24.25% | ||
| Current year | -26.12% |
| 1 week | 25.16 |  | 31.26 |
| 1 month | 23.16 | | 40 |
| Current year | 19.22 | | 41.64 |
| 1 year | 19.22 | | 55.85 |
| 3 years | 14.8 | | 56.55 |
| 5 years | 14.8 | | 292.2 |
| 10 years | 14.8 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dong Xu Qiu
PRN | Corporate Officer/Principal | 66 | 21/02/2024 |
Hui Hua Mao
PRN | Corporate Officer/Principal | 64 | 13/01/2009 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 13/01/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Yu
CHM | Chairman | 62 | 13/01/2009 |
Zhong Qi Shao
BRD | Director/Board Member | 63 | 28/05/2021 |
Shou Bai Chao
BRD | Director/Board Member | 63 | 22/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/08/25 | Sell | Director | 4,600 | 0.0069% | ||
| 26/09/24 | Other | Chief Executive Officer | 20,000 | 0.0151% | ||
| 09/09/24 | Other | Founder | 30,000 | 0.0226% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.87% | -11.70% | -52.53% | +9.79% | 151.56Cr | |
| -1.48% | -5.59% | +39.55% | -6.16% | 7.8TCr | |
| +5.38% | -1.09% | +512.38% | +36.80% | 5.75TCr | |
| -1.42% | -4.24% | -19.59% | -38.20% | 5.74TCr | |
| -0.56% | -2.21% | -11.34% | +27.29% | 4.88TCr | |
| +1.93% | -2.37% | -0.87% | +149.45% | 4.55TCr | |
| +0.80% | -1.67% | +49.90% | -15.98% | 3.21TCr | |
| -1.47% | -4.17% | +46.17% | +89.12% | 2.46TCr | |
| -0.85% | -8.64% | -4.39% | +161.31% | 2.08TCr | |
| -0.09% | -3.61% | +62.49% | +98.37% | 1.57TCr | |
| Average | -0.16% | -4.66% | +62.18% | +51.18% | 3.82TCr | |
| Weighted average by Cap. | +0.36% | -3.74% | +89.99% | +37.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 144.03Cr 168.38Cr 21Cr 18Cr 18Cr 16Cr 30Cr 2.05TCr 30Cr 208.02Cr 80Cr 1.04TCr 81Cr 79Cr 3.3TCr | 181.22Cr 211.85Cr 27Cr 23Cr 22Cr 20Cr 37Cr 2.58TCr 38Cr 261.73Cr 100.65Cr 1.31TCr 101.45Cr 99Cr 4.15TCr |
| Net income | 11Cr 13Cr 1.59Cr 1.37Cr 1.3Cr 1.18Cr 2.21Cr 152.37Cr 2.22Cr 15Cr 5.94Cr 78Cr 5.99Cr 5.86Cr 244.96Cr | 32Cr 38Cr 4.8Cr 4.14Cr 3.92Cr 3.55Cr 6.66Cr 458.87Cr 6.7Cr 47Cr 18Cr 233.45Cr 18Cr 18Cr 737.68Cr |
| Net Debt | 2.4Cr 2.81Cr 35.8L 30.85L 29.21L 26.48L 49.67L 34Cr 49.92L 3.47Cr 1.33Cr 17Cr 1.34Cr 1.32Cr 55Cr | 42Cr 49Cr 6.19Cr 5.33Cr 5.05Cr 4.58Cr 8.58Cr 591.12Cr 8.63Cr 60Cr 23Cr 300.74Cr 23Cr 23Cr 950.3Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | HK$25.80 | -3.87% | 32,73,454 |
| 10/26/10 | HK$26.84 | -6.35% | 39,77,000 |
| 09/26/09 | HK$28.66 | -2.78% | 36,75,227 |
| 08/26/08 | HK$29.48 | +3.44% | 1,16,68,000 |
| 07/26/07 | HK$28.50 | -2.46% | 26,92,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6185 Stock
Select your edition
All financial news and data tailored to specific country editions
